Hyatt Hotels Corporation H
183.45 USD -6.73 (-3.54%)
Nov 5, 2026, 2:29 PM EST
182.77 Day range 190.69
137.53 52-week range 206.86
- YTD
- +14.43%
- 1 year
- +32.93%
Analyst view
Consensus: buy
Buy
Price target (mean) 201.52 +9.9% upside
Now 183.45
- Target (low)
- 168.00
- Target (mean)
- 201.52
- Target (high)
- 228.00
Ratings (0m) 25 16 buy · 9 hold · 0 sell
- Strong buy3
- Buy13
- Hold9
- Sell0
- Strong sell0
Recommendation trend
- This month 25
- 1 month ago 25
- 2 months ago 24
- 3 months ago 23
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.01 | 0.53 – 1.52 | 1.33 | -24.3% | 1.80B | +0.5% | 16 |
| Next quarter | 0.95293 | 0.66333 – 1.43 | 0.63 | +51.3% | 1.89B | +8.3% | 15 |
| Current year | 3.93 | 3.34 – 4.53 | 2.19 | +79.4% | 7.13B | +0.3% | 19 |
| Next year | 4.92 | 3.90 – 6.23 | 3.93 | +25.3% | 7.70B | +8.1% | 24 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Freedom Broker | Maintained | Buy | Buy |
| Nov 2, 2026 | Baird | Maintained | Neutral | Neutral |
| Oct 30, 2026 | Macquarie | Maintained | Outperform | Outperform |
| Oct 30, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 22, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 21, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 19, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 16, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 14, 2026 | Freedom Broker | Initiated | — | Buy |
| Oct 13, 2026 | Susquehanna | Maintained | Neutral | Neutral |
| Oct 12, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 8, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Sep 10, 2026 | Truist Securities | Maintained | Buy | Buy |
| Sep 2, 2026 | Wolfe Research | Initiated | — | Outperform |
| Aug 18, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 11, 2026 | Susquehanna | Maintained | Neutral | Neutral |
| Aug 3, 2026 | Baird | Maintained | Neutral | Neutral |
| Jul 31, 2026 | Macquarie | Maintained | Outperform | Outperform |
| Jul 31, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 31, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 21, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Jul 21, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 21, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 17, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 16, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 14, 2026 | Macquarie | Maintained | Outperform | Outperform |
| Jun 1, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 1, 2026 | Baird | Maintained | Neutral | Neutral |
| May 29, 2026 | JP Morgan | Maintained | Overweight | Overweight |
